These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26144370)

  • 1. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
    Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
    Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
    Kim JH; Bae KH; Choi YK; Go Y; Choe M; Jeon YH; Lee HW; Koo SH; Perfield JW; Harris RA; Lee IK; Park KG
    Diabetes Obes Metab; 2015 Feb; 17(2):161-9. PubMed ID: 25359298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
    Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
    Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
    Yu D; Ye X; Wu Q; Li S; Yang Y; He J; Liu Y; Zhang X; Yuan Q; Liu M; Li D; Ren G
    Endocrine; 2016 Jun; 52(3):527-40. PubMed ID: 26607153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.
    Shao M; Yu L; Zhang F; Lu X; Li X; Cheng P; Lin X; He L; Jin S; Tan Y; Yang H; Zhang C; Cai L
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(1):E45-54. PubMed ID: 25968574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of the role of fibroblast growth factor 21 in attenuating insulin resistance].
    Xu TY; Wang WF; Xu PF; Yuan QY; Liu SQ; Zhnag T; Ren GP; Li DS
    Yao Xue Xue Bao; 2015 Sep; 50(9):1101-6. PubMed ID: 26757545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine restriction prevents onset of type 2 diabetes in NZO mice.
    Castaño-Martinez T; Schumacher F; Schumacher S; Kochlik B; Weber D; Grune T; Biemann R; McCann A; Abraham K; Weikert C; Kleuser B; Schürmann A; Laeger T
    FASEB J; 2019 Jun; 33(6):7092-7102. PubMed ID: 30841758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.
    Adams AC; Halstead CA; Hansen BC; Irizarry AR; Martin JA; Myers SR; Reynolds VL; Smith HW; Wroblewski VJ; Kharitonenkov A
    PLoS One; 2013; 8(6):e65763. PubMed ID: 23823755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
    Li S; Wang N; Guo X; Li J; Zhang T; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():355-366. PubMed ID: 30227329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats.
    Pedersen C; Porsgaard T; Thomsen M; Rosenkilde MM; Roed NK
    PLoS One; 2018; 13(3):e0194468. PubMed ID: 29558502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.